| Literature DB >> 33365097 |
Thiago Scremin Boscolo Pereira1,2, Camila Nomura Pereira Boscolo1, Renata Guimarães Moreira3, Sergio Ricardo Batlouni4.
Abstract
Several studies have been developed to support the replacement of the crude carp pituitary extract (CPE) by synthetic products for induced reproduction of South American rheophilic species. However, results have been quite heterogeneous and there is no consensus or a routine use of synthetic products in these species. Thus, the aim of this study was to evaluate the ovulatory process in L. elongatus using different protocols of hormonal induction. Thus, fifteen wild mature females maintained at the Experimental Fish Station, Salto Grande, SP, Brazil were submitted to three different hormonal treatments: CPE (fractioned dose: 0.5 and 5.0 mg kg-1); mGnRHa (single dose: 3.5 µg kg-1) and mGnRHa (single dose: 5.0 µg kg-1). The spawning rate and absolute fecundity were similar among the treatments, but fertility rates were higher for CPE treatment (23.60 ± 9.40) then for mGnRHa treatments (close to or zero zero). Although females ovulated in all treatments, none of them provided viable embryos, showing hatching rates close to zero or zero. Both mGnRHa treatments were more potent for inducing the ovulatory process then CPE treatment, which was evidenced by the fact that the formers showed higher volume density of postovulatory follicles (POF). Accordingly, E2 and 17α-OHP plasma levels were higher for the mGnRHa treated females compared to the CPE one at the time of ovulation. In this study we confirmed previous scientific evidence that, regardless of whether promoting ovulation, the use of conventional CPE and GnRH doses are not appropriate for some South American migratory species, due to the non-attainment of viable embryos. Moreover, we have brought new information about the relationship between reproductive performance and gonadal steroids concentrations using different hormonal therapies, contributing to understand the reasons for Leporinus elongatus embryo loss in induced spawning.Entities:
Keywords: final maturation; gonadal steroids; hormonal treatment; ovulation; spawning performance
Year: 2018 PMID: 33365097 PMCID: PMC7746223 DOI: 10.21451/1984-3143-2017-AR983
Source DB: PubMed Journal: Anim Reprod ISSN: 1806-9614 Impact factor: 1.807
Average values (± Standard error) of the reproductive performance of female L. elongatus undergoing hormonal induction.
| Treatments | Latency period (h) | Spawning rate (%) | Absolute fecundity (oocyte/fish) | GSI (%) |
Fertility rate
|
Hatching rate
|
|---|---|---|---|---|---|---|
| CPE | 18.50 ± 0.20a | 80.00 ± 25.08a | 84.334 ± 32.98a | 16.49 ± 0.58a | 23.60 ± 9.40a | 1.3 ± 1.0a |
| mGnRHa (3.5 µg/kg−1) | 15.40 ± 0.11b | 100.00 ± 0.00a | 97.239 ± 12.45a | 12.80 ± 2.98a | 1.40 ± 0.60b | 0.4 ± 0.2a |
|
mGnRHa
| 15.20 ± 0.09b | 100.00 ± 0.00a | 95.338 ± 15.23a | 11.58 ± 3.67a | 0 ± 0 b | 0 ± 0 a |
CPE: carp pituitary extract and mGnRHa: mammalian gonadotropin-releasing hormone analogue. Different letters indicate differences between treatments (P < 0.05).
Figure 1Percentage average values (± Standard error) of the volume density of different types of ovulated ovarian oocytes collected at the time of ovulation (n = 5 per treatment). Different letters indicate significant difference between treatments (P < 0.05). Oocytes: PV (previtellogenic); CA (cortical alveoli); IV (immature vitellogenic); CNV (vitellogenic oocytes with central nucleus); MNV (mature vitellogenic oocytes with migrated nucleus); GVBD (mature vitellogenic oocyte with germinal vesicle breakdown); POF (postovulatory follicle); AT (atretic) and TI (interstitial tissue). CPE: carp pituitary extract; mGnRHa: gonadotropin-releasing hormone.
Figure 2(A) Photomicrographs of cross sections of the ovary of L. elongatus females induced with CPE containing large amount of GVBD and CNV oocytes retained in post-spawning ovaries. (B) Photomicrographs of cross sections of the ovary of L. elongatus females induced with mGnRHa containing large amount of POF.
Average values (± Standard error) of plasma levels of estradiol (E2 ) and 17α – hydroxyprogesterone (17α – OHP) at different times during hormonal induction.
| Treatments | Period | |||
|---|---|---|---|---|
| E2 |
First dose
|
Second dose
|
Ovulation
| |
| CPE | 129,27 ± 26.26aB | 132.15 ± 15.67bB | 74.17 ± 28.96aA | |
| mGnRHa (3.5 µg/kg−1) | 154.45 ± 13.54aA | - | 132.06 ± 15.87bA | |
| mGnRHa (5.0 µg/kg−1) | 127.82 ± 20.91aA | - | 150.60 ± 10.75bA | |
| 17α – OHP | ||||
| CPE | 198.08 ± 9.87aB | 201.15 ± 5.22bB | 229.87 ± 15.82aA | |
| mGnRHa (3.5 µg/kg−1) | 189.10 ± 29.05aB | - | 376.04 ± 24.37bA | |
| mGnRHa (5.0 µg/kg−1) | 153.72 ± 64.89aA | - | 401.10 ± 8.45bA | |
CPE: Carp pituitary extract and mGnRHa: mammalian Gonadotropin-releasing hormone analogue. Different letters indicate differences between treatments (P < 0.05). Different lowercase letters indicate differences between different treatments for the same periods and different capital letters indicate differences between the same treatment in different periods (P < 0.05).